Noting “[w]e are just three years away from the target date for achieving the U.N. Millennium Development Goals (MDGs) agreed by all … U.N. member states back in 2000 to eradicate global poverty,” Peter Piot, director of the London School of Hygiene and Tropical Medicine, in this Independent opinion piece reflects “on the critical role of health in and beyond the Millennium Development Goals” ahead of the second meeting of the U.N. Secretary General’s High-Level Panel on the future strategy to fight global poverty, set to take place in London on Wednesday. Piot writes that the MDGs have “given local and global focus to efforts to tackle the big issues,” while inspiring action, innovation, and new financing models, but he notes “there is still so much more we need to do.”
Programs, Funding & Financing
The Centers for Disease Control and Prevention (CDC) on Monday released a 268-page annual report that “profiles a wide range of CDC influenza-related projects around the world, from flu surveillance in Indonesia to vaccine effectiveness studies in El Salvador and epidemiology training in Ghana,” CIDRAP News reports. The report also “describes the CDC’s collaborations with the World Health Organization (WHO), outlines projects it supports in about 40 countries, … describes specific studies undertaken in many of those countries,” “lists international training conferences it has sponsored, and describes the CDC program for sharing diagnostic test kits and reagents,” the news service writes. “Over the past six years the [international] program has undergone remarkable growth and has expanded to provide support to over 40 countries, all WHO regional offices and WHO headquarters,” the report notes, according to CIDRAP. “The report, covering 2011, is the third annual account of the agency’s global flu activities, which have expanded greatly in the past decade,” the news service adds (Roos, 10/30).
“The U.K. has announced that Â£35 million ($56 million) in aid over the next three years will be aimed at improving nutrition for mothers and children in Yemen amid fears that a hunger crisis will derail fragile gains in the Middle East’s poorest country,” the Guardian reports. “More than 10 million people in Yemen, a country with a population of around 24.7 million, are thought to be at risk because of insufficient food,” and “[i]n the worst-affected parts of the country, as many as one in three children are suffering from life-threatening acute malnutrition,” the newspaper notes. “The U.K. funding will go towards long-term support to help improve nutrition for 1.65 million women and children in 60 of the most vulnerable, deprived and conflict-affected districts in the eight governorates where the need is greatest,” according to the Guardian (Tran, 10/10).
In a BMJ Group Blogs post, Caroline Robinson, global health advocacy manager for Results U.K., discusses the prevalence and treatment of tuberculosis (TB) and drug-resistant TB in Europe and provides the example of Romania. She writes, “[E]vidence brought to light in a new report [.pdf] released recently outlining the effect funding shortages will have on HIV and TB, including drug-resistant TB, in the European region suggests that Romania does not have the institutional capacity to ensure its citizens have the basic right to health. The country relies on grants from the Global Fund to Fight AIDS, Tuberculosis, and Malaria, which look set to end in 2013.” She continues, “[Global Fund] Board members should ensure that middle-income countries with epidemics among key populations can access critical Global Fund contributions and the E.U. and its member states must continue to provide the resources the fund requires to meet demand. Unless such support is given, countries like Romania will continue to fall further down the league tables in terms of treatment for this curable disease” (10/10).
Gender Action recently released a new report (.pdf), titled “Banking on Health: World Bank and African Development Bank Spending on Reproductive Health and HIV/AIDS in Sub-Saharan Africa,” according to the organization’s website. The report, based on fieldwork in Cameroon and Uganda, “reviews World Bank and AfDB projects to highlight how good quality matters as much as high quantity in reproductive and sexual health and HIV/AIDS spending,” the website notes. In addition to the report, Gender Action created a database (.xls) “containing comprehensive information about World Bank and AfDB investments (2000-2012) addressing reproductive health and HIV/AIDS in sub-Saharan African countries,” the website states (10/9).
According to a press release from the Global Fund to Fight AIDS, Tuberculosis and Malaria, the fund’s Board on Friday “voted to adopt a new approach to funding grants that will enable the organization to invest the world’s money more strategically and for greater impact.” The press release notes “the new funding model will change the way implementers apply for financing, get approval of their proposals and then manage their grants,” and it describes the changes in more detail. “In its decision, the Board agreed that the new model should enhance participation by all stakeholders, including civil society and will support continued funding for the needs of most-at-risk populations, so that concentrated epidemics are taken into consideration,” the press release states, adding, “The Board also requested a regular evaluation of the new funding model, and asked the Board’s Strategy Investment and Impact Committee to continue working out the details of the funding model so that implementation can begin in 2013” (9/14).
OMB Report On Budgetary Impact Of Sequestration Estimates Global Health Funding Would Decrease By 8.2%
The White House Office of Management and Budget (OMB) on Friday released a report (.pdf) describing the budgetary impacts of sequestration “mandated by the 2011 Budget Control Act,” which would require an annual reduction in government spending of $109 billion per year for nine years, National Journal reports. “Sequestration will go into effect starting Jan. 2 unless Congress can reach a deficit-reduction deal to head it off,” the news service notes (O’Donnell et al., 9/14). “According to the report, global health funding through USAID and State Department, which comprises the majority of U.S. global health funding, would decrease by $670 million, or 8.2 percent, from the FY 2012 level of $8,168 million,” according to the Kaiser Family Foundation’s “Policy Tracker” (9/14).
Global Health Funding Cuts Threatening Fight Against HIV, TB In Eastern Europe, Central Asia, NGO Report Says
The fight against HIV and tuberculosis (TB) in Eastern Europe and Central Asia is being threatened by cuts in global health funding, according to “a report [.pdf] by leading European non-governmental health organizations,” Reuters reports. In the report, “experts called on the European Union to step in to fill the gaps left by global donors to countries within and neighboring its borders,” the news service notes. According to Reuters, “[c]ountries in Eastern Europe and Central Asia have some of the world’s fastest growing HIV epidemics,” and “Europe is also home to the world’s highest documented rates of drug-resistant TB” (Kelland, 9/18).
“The Chinese drug industry is on the verge of getting the green light to manufacture the Japanese encephalitis vaccine for the developing world, an event that will signal the emergence of a major new player in global vaccines,” BMJ reports. Seth Berkley, chief executive of the GAVI Alliance, “said that by the beginning of next year Chinese drug firms will be ready for World Health Organization representatives to carry out pre-qualification inspections of production of the vaccine,” the journal writes, adding, “Once those inspections are carried out, United Nations agencies and other non-governmental organizations will be able to purchase the vaccine for countries that do not have their own regulatory systems.”
In this post in the Center for Global Development’s (CGD) “Global Health Policy” blog, Victoria Fan, a CGD research fellow, and Rachel Silverman, a research assistant for the global health team at the center, examine the future of UNITAID. “Perhaps due to its relative obscurity and late entry to a crowded global health field, UNITAID has proactively worked to differentiate itself through a focus on commodities, market shaping, novel funding sources, and innovation,” but, “as UNITAID celebrates its sixth birthday …, it stands at a potential crossroads,” they write. Fan and Silverman note that a five-year evaluation report on the future of UNITAID, commissioned by its Executive Board, is forthcoming, and they highlight a paper (.pdf) in which they “outline some contradictions and limitations of UNITAID’s current approach.” They write, “We hope that the imminent evaluation provides the impetus for UNITAID to turn inward and do something truly innovative: buck institutional inertia, change course as necessary, and reinvent itself as the solution to 2012’s biggest global health challenges” (9/17).